MAPT and Parkinson disease: A similar lack of efficacy was reported for p-tau181 in differentiating multisystem atrophy from other parkinsonisms [6,11,19], further supporting the concept that tau hyperphosphorylation is a shared feature in neurodegenerative parkinsonian disorders [2].